Need immediate assistance? Call 1-518-730-0559 (Us-Canada Toll Free) or Contact Us

 

Biological Imaging Reagents Market – Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2019 – 2027

Table of Content

1. Preface

    1.1. Market Definition and Scope

    1.2. Market Segmentation

    1.3. Key Research Objectives

    1.4. Research Highlights

2. Assumptions and Research Methodology

3. Executive Summary: Global Biological Imaging Reagents Market

4. Market Overview

    4.1. Introduction

        4.1.1. Class Definition

        4.1.2. Industry Evolution / Developments

    4.2. Overview

    4.3. Market Dynamics

        4.3.1. Drivers

        4.3.2. Restraints

        4.3.3. Opportunities

    4.4. Global Biological Imaging Reagents Market Analysis and Forecast, 2017–2027

        4.4.1. Market Revenue Projections (US$ Mn)

    4.5. Porter’s Five Force Analysis

5. Market Outlook

    5.1. Regulatory Scenario by Region/globally

    5.2. Technological Advancements

    5.3. Disease Prevalence & Incidence Rate globally with key countries

6. Global Biological Imaging Reagents Market Analysis and Forecast, by Class, 2017–2027 

    6.1. Introduction & Definition

    6.2. Key Findings / Developments

    6.3. Market Value Forecast, by Class, 2017–2027

        6.3.1. Contrast Reagents

        6.3.2. Optical Reagents

        6.3.3. Nuclear Reagents

    6.4. Market Attractiveness, by Class 

7. Global Biological Imaging Reagents Market Analysis and Forecast, by Modality, 2017–2027 

    7.1. Introduction & Definition

    7.2. Key Findings / Developments

    7.3. Market Value Forecast, by Modality, 2017–2027

        7.3.1. MRI

        7.3.2. Ultrasound

        7.3.3. X-ray & CT

        7.3.4. Nuclear

            7.3.4.1. PET

            7.3.4.2. SPECT

        7.3.5. Optical Imaging

        7.3.6. Others

    7.4. Market Attractiveness, by Modality 

8. Global Biological Imaging Reagents Market Analysis and Forecast, by Application

    8.1. Introduction & Definition

    8.2. Key Findings / Developments

    8.3. Market Value Forecast, by Application, 2017–2027

        8.3.1. In Vitro

            8.3.1.1. Proteomics

            8.3.1.2. Genomics

            8.3.1.3. Cell Biology

        8.3.2. In Vivo

    8.4. Market Attractiveness, by Application

9. Global Biological Imaging Reagents Market Analysis and Forecast, by End-user, 2017–2027 

    9.1. Introduction & Definition

    9.2. Key Findings / Developments

    9.3. Market Value Forecast, by End-user, 2017–2027

        9.3.1. Diagnostic Laboratories

        9.3.2. Imaging Centers

        9.3.3. Life Sciences Companies

        9.3.4. Academic & Research Institutes

        9.3.5. Others

    9.4. Market Attractiveness, by End-user 

10. Global Biological Imaging Reagents Market Analysis and Forecasts, by Region, 2017–2027

    10.1. Key Findings

    10.2. Market Value Forecast, by Region

        10.2.1. North America 

        10.2.2. Europe 

        10.2.3. Asia Pacific 

        10.2.4. Latin America 

        10.2.5. Middle East & Africa 

    10.3. Market Attractiveness, by Country/Region

11. North America Biological Imaging Reagents Market Analysis and Forecast, 2017–2027

    11.1.Introduction

        11.1.1. Key Findings

    11.2. Market Value Forecast, by Class, 2017–2027

        11.2.1. Contrast Reagents

        11.2.2. Optical Reagents

        11.2.3. Nuclear Reagents

    11.3. Market Value Forecast, by Modality, 2017–2027

        11.3.1. MRI

        11.3.2. Ultrasound

        11.3.3. X-ray & CT

        11.3.4. Nuclear

            11.3.4.1. PET

            11.3.4.2. SPECT

        11.3.5. Optical Imaging

        11.3.6. Others

    11.4. Market Value Forecast, by Application, 2017–2027

        11.4.1. In Vitro

            11.4.1.1. Proteomics

            11.4.1.2. Genomics

            11.4.1.3. Cell Biology

        11.4.2. In Vivo

    11.5. Market Value Forecast, by End-user, 2017–2027

        11.5.1. Diagnostic Laboratories

        11.5.2. Imaging Centers

        11.5.3. Life Sciences Companies

        11.5.4. Academic & Research Institutes

        11.5.5. Others

    11.6. Market Value Forecast, by Country, 2017–2027

        11.6.1. U.S.

        11.6.2. Canada

    11.7. Market Attractiveness Analysis 

        11.7.1. By Class 

        11.7.2. By Modality 

        11.7.3. By Application

        11.7.4. By End-user 

        11.7.5. By Country

12. Europe Biological Imaging Reagents Market Analysis and Forecast, 2017–2027

    12.1. Introduction

        12.1.1. Key Findings

    12.2. Market Value Forecast, by Class, 2017–2027

        12.2.1. Contrast Reagents

        12.2.2. Optical Reagents

        12.2.3. Nuclear Reagents

    12.3. Market Value Forecast, by Modality, 2017–2027

        12.3.1. MRI

        12.3.2. Ultrasound

        12.3.3. X-ray & CT

        12.3.4. Nuclear

            12.3.4.1. PET

            12.3.4.2. SPECT

        12.3.5. Optical Imaging

        12.3.6. Others

    12.4. Market Value Forecast, by Application, 2017–2027

        12.4.1. In Vitro

            12.4.1.1. Proteomics

            12.4.1.2. Genomics

            12.4.1.3. Cell Biology

        12.4.2. In Vivo

    12.5. Market Value Forecast, by End-user, 2017–2027

        12.5.1. Diagnostic Laboratories

        12.5.2. Imaging Centers

        12.5.3. Life Sciences Companies

        12.5.4. Academic & Research Institutes

        12.5.5. Others

    12.6. Market Value Forecast, by Country/Sub-region, 2017–2027

        12.6.1. Germany

        12.6.2. U.K.

        12.6.3. France

        12.6.4. Spain

        12.6.5. Italy

        12.6.6. Rest of Europe

    12.7. Market Attractiveness Analysis 

        12.7.1. By Class 

        12.7.2. By Modality 

        12.7.3. By Application

        12.7.4. By End-user 

        12.7.5. By Country/Sub-region

13. Asia Pacific Biological Imaging Reagents Market Analysis and Forecast, 2017–2027

    13.1. Introduction

        13.1.1. Key Findings

    13.2. Market Value Forecast, by Class, 2017–2027

        13.2.1. Contrast Reagents

        13.2.2. Optical Reagents

        13.2.3. Nuclear Reagents

    13.3. Market Value Forecast, by Modality, 2017–2027

        13.3.1. MRI

        13.3.2. Ultrasound

        13.3.3. X-ray & CT

        13.3.4. Nuclear

            13.3.4.1. PET

            13.3.4.2. SPECT

        13.3.5. Optical Imaging

        13.3.6. Others

    13.4. Market Value Forecast, by Application, 2017–2027

        13.4.1. In Vitro

            13.4.1.1. Proteomics

            13.4.1.2. Genomics

            13.4.1.3. Cell Biology

        13.4.2. In Vivo

    13.5. Market Value Forecast, by End-user, 2017–2027

        13.5.1. Diagnostic Laboratories

        13.5.2. Imaging Centers

        13.5.3. Life Sciences Companies

        13.5.4. Academic & Research Institutes

        13.5.5. Others

    13.6. Market Value Forecast, by Country/Sub-region, 2017–2027

        13.6.1. China

        13.6.2. Japan

        13.6.3. India

        13.6.4. Australia & New Zealand

        13.6.5. Rest of Asia Pacific

    13.7. Market Attractiveness Analysis 

        13.7.1. By Class 

        13.7.2. By Modality 

        13.7.3. By Application

        13.7.4. By End-user 

        13.7.5. By Country/Sub-region

14. Latin America Biological Imaging Reagents Market Analysis and Forecast, 2017–2027

    14.1. Introduction

        14.1.1. Key Findings

    14.2. Market Value Forecast, by Class, 2017–2027

        14.2.1. Contrast Reagents

        14.2.2. Optical Reagents

        14.2.3. Nuclear Reagents

    14.3. Market Value Forecast, by Modality, 2017–2027

        14.3.1. MRI

        14.3.2. Ultrasound

        14.3.3. X-ray & CT

        14.3.4. Nuclear

            14.3.4.1. PET

            14.3.4.2. SPECT

        14.3.5. Optical Imaging

        14.3.6. Others

    14.4. Market Value Forecast, by Application, 2017–2027

        14.4.1. In Vitro

            14.4.1.1. Proteomics

            14.4.1.2. Genomics

            14.4.1.3. Cell Biology

        14.4.2. In Vivo

    14.5. Market Value Forecast, by End-user, 2017–2027

        14.5.1. Diagnostic Laboratories

        14.5.2. Imaging Centers

        14.5.3. Life Sciences Companies

        14.5.4. Academic & Research Institutes

        14.5.5. Others

    14.6. Market Value Forecast, by Country/Sub-region, 2017–2027

        14.6.1. Brazil

        14.6.2. Mexico

        14.6.3. Rest of Latin America

    14.7. Market Attractiveness Analysis 

        14.7.1. By Class 

        14.7.2. By Modality 

        14.7.3. By Application

        14.7.4. By End-user 

        14.7.5. By Country/Sub-region

15. Middle East & Africa Biological Imaging Reagents Market Analysis and Forecast, 2017–2027

    15.1. Introduction

        15.1.1. Key Findings

    15.2. Market Value Forecast, by Class, 2017–2027

        15.2.1. Contrast Reagents

        15.2.2. Optical Reagents

        15.2.3. Nuclear Reagents

    15.3. Market Value Forecast, by Modality, 2017–2027

        15.3.1. MRI

        15.3.2. Ultrasound

        15.3.3. X-ray & CT

        15.3.4. Nuclear

            15.3.4.1. PET

            15.3.4.2. SPECT

        15.3.5. Optical Imaging

        15.3.6. Others

    15.4. Market Value Forecast, by Application, 2017–2027

        15.4.1. In Vitro

            15.4.1.1. Proteomics

            15.4.1.2. Genomics

            15.4.1.3. Cell Biology

        15.4.2. In Vivo

    15.5. Market Value Forecast, by End-user, 2017–2027

        15.5.1. Diagnostic Laboratories

        15.5.2. Imaging Centers

        15.5.3. Life Sciences Companies

        15.5.4. Academic & Research Institutes

        15.5.5. Others

    15.6. Market Value Forecast, by Country/Sub-region, 2017–2027

        15.6.1. GCC Countries

        15.6.2. South Africa

        15.6.3. Rest of Middle East & Africa

    15.7. Market Attractiveness Analysis 

        15.7.1. By Class 

        15.7.2. By Modality 

        15.7.3. By Application 

        15.7.4. By End-user 

        15.7.5. By Country/Sub-region

16. Competition Landscape

    16.1. Market Player – Competition Matrix (By Tier and Size of companies)

    16.2. Market Position/Ranking Analysis, by Company (2018)

    16.3. Company Profiles

        16.3.1. Bayer AG

            16.3.1.1. Company Overview (HQ, Business Segments, Employee Strength)

            16.3.1.2. Company Financials

            16.3.1.3. Growth Strategies

            16.3.1.4. SWOT Analysis

        16.3.2. Thermo Fisher Scientific, Inc.

            16.3.2.1. Company Overview (HQ, Business Segments, Employee Strength)

            16.3.2.2. Company Financials

            16.3.2.3. Growth Strategies

            16.3.2.4. SWOT Analysis

        16.3.3. PerkinElmer, Inc.

            16.3.3.1. Company Overview (HQ, Business Segments, Employee Strength)

            16.3.3.2. Company Financials

            16.3.3.3. Growth Strategies

            16.3.3.4. SWOT Analysis

        16.3.4. Guerbet

            16.3.4.1. Company Overview (HQ, Business Segments, Employee Strength)

            16.3.4.2. Company Financials

            16.3.4.3. Growth Strategies

            16.3.4.4. SWOT Analysis

        16.3.5. Lantheus Holdings, Inc.

            16.3.5.1. Company Overview (HQ, Business Segments, Employee Strength)

            16.3.5.2. Company Financials

            16.3.5.3. Growth Strategies

            16.3.5.4. SWOT Analysis

        16.3.6. Bracco S.p.A.

            16.3.6.1. Company Overview (HQ, Business Segments, Employee Strength)

            16.3.6.2. Company Financials

            16.3.6.3. Growth Strategies

            16.3.6.4. SWOT Analysis

        16.3.7. GE Healthcare

            16.3.7.1. Company Overview (HQ, Business Segments, Employee Strength)

            16.3.7.2. Company Financials

            16.3.7.3. Growth Strategies

            16.3.7.4. SWOT Analysis

        16.3.8. Becton, Dickinson and Company (BD)

            16.3.8.1. Company Overview (HQ, Business Segments, Employee Strength)

            16.3.8.2. Company Financials

            16.3.8.3. Growth Strategies

            16.3.8.4. SWOT Analysis

        16.3.9. Siemens Healthineers

            16.3.9.1. Company Overview (HQ, Business Segments, Employee Strength)

            16.3.9.2. Company Financials

            16.3.9.3. Growth Strategies

            16.3.9.4. SWOT Analysis

        16.3.10. Luminex Corporation

            16.3.10.1. Company Overview (HQ, Business Segments, Employee Strength)

            16.3.10.2. Company Financials

            16.3.10.3. Growth Strategies

            16.3.10.4. SWOT Analysis

Custom Market Research Services

MRRSE offers custom market research services that help clients to get information on their business scenario required where syndicated solutions are not enough.

Get A Free Custom Research Quote